Crohn-betegség: vizsgálatok itt: Franciaország
82 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
- Where
- Amiens Cedex 1, Besançon, Clichy, Creteil Cedex, Dijon, Échirolles, Le Kremlin-Bicetre, Lille Cedex, Marseille, Nantes, Neuilly-Sur-Seine, Nice, Nimes Cedex 9, Paris, Pierre-Bénite, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 567 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-518296-56-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Where
- Amiens Cedex 1, Besancon Cedex, Clichy, Creteil, Dijon, Échirolles, Le Kremlin-Bicetre, Lille Cedex, Marseille, Montpellier Cedex 5, Nantes, Neuilly-Sur-Seine, Nice, Nimes Cedex 9, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 16 év to 80 év
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00 - 3. fázisTaking peopleExtension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Where
- Lille Cedex, Neuilly-Sur-Seine, Nice, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 1380 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00 - No phaseTaking peopleIbd CAncer and seRious Infections in France (I-CARE 2)
- Where
- Amiens, Paris
- Életkor
- 18 év to 75 év
- People
- 6000
- Run by
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
See details and how to joinNCT06089590 - No phaseTaking peopleCharacterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
- Where
- Amiens, Besançon
- Életkor
- 18 év and over
- People
- 800
- Run by
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
See details and how to joinNCT07719426 - 2. fázisTaking peopleA Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Where
- Pierre-Bénite, Saint-Priest-en-Jarez, Vandoeuvre Les Nancy
- Életkor
- 18 év to 85 év
- People
- 385 worldwide
- Run by
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen, Saint-Priest-en-Jarez, Toulouse
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 4. fázisTaking peopleEfficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
- Where
- Amiens, Besançon Cedex, Brest, Caen Cedex 9, Clermont-Ferrand cedex, Créteil, Lille Cedex, Nice, Nîmes, Paris, Poitiers, Toulouse cedex 9, Valence
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
See details and how to joinNCT07292012 · EU 2025-521889-95-00 - 3. fázisTaking peopleA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Where
- Amiens Cedex 1, Lille Cedex, Paris
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Lille Cedex
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 2/3. fázisTaking peopleA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Bayonne, Clermont-Ferrand, Creteil, Échirolles, Lille, Montfermeil, Montpellier Cedex 5, Nancy Cedex, Nantes, Nice, Paris, Pierre-Bénite, Saint-Priest-en-Jarez, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 1092 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00 - 3. fázisTaking peopleA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Amiens, Clermont-Ferrand, Échirolles, Marseille, Nantes, Neuilly-sur-Seine, Nîmes, Paris, Pierre-Bénite, Reims, Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 530 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07499232 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Amiens Cedex 1, Besancon Cedex, Clichy, Creteil, Le Kremlin-Bicetre, Lille, Montpellier Cedex 5, Nancy Cedex, Nantes, Neuilly-Sur-Seine, Nice, Pessac, Pierre-Bénite, Reims Cedex, Saint-Priest-en-Jarez, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00 - 2. fázisTaking peopleA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Where
- Chambray Les Tours, Clermont-Ferrand, Nancy Cedex, Neuilly-Sur-Seine, Nice, Paris Cedex 12, Saint-Priest-en-Jarez
- Életkor
- 18 év to 75 év
- People
- 268 worldwide
- Run by
- Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Where
- Montpellier Cedex 5, Nice, Saint-Priest-en-Jarez, Toulouse Cedex 9
- Életkor
- 18 év to 75 év
- People
- 99 worldwide
- Run by
- Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Chambray Les Tours, Clermont-Ferrand, Creteil Cedex, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Montpellier Cedex 5, Neuilly-Sur-Seine, Paris, Pierre-Bénite, Saint-Priest-en-Jarez, Vandoeuvre Les Nancy
- Életkor
- 16 év to 80 év
- People
- 425 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06819891 · EU 2024-513054-30-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Amiens, Besançon, Créteil, La Tronche, Lille, Marseille, Nantes, Nice, Paris, Saint-Etienne, Toulouse, Vandœuvre-lès-Nancy
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184931 - No phaseTaking peopleVirtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions
- Where
- Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 60
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT07413653 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Where
- Bordeaux, Bron, Paris, Toulouse Cedex 9, Tours
- Életkor
- 2 év to 17 év
- People
- 110 worldwide
- Run by
- AbbVie
See details and how to joinNCT05995353 · EU 2022-502050-14-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Amiens Cedex 1, Marseille, Nice, Pessac Cedex, Reims Cedex, Rennes Cedex 9, Saint-Priest-en-Jarez
- Életkor
- 16 év to 80 év
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00 - 2. fázisTaking peopleA clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
- Where
- Besançon, Clichy, Marseille, Neuilly-Sur-Seine, Paris Cedex 18, Rennes
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Agomab Spain S.L.U.
See details and how to join2026-525197-19-00 - No phaseNot yet taking people in FranciaországEffect of Intestinal Carriage of *Pilosibacter Rotomagensis* on Intestinal Inflammatory Activity
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 116
- Run by
- University Hospital, Rouen
See details and how to joinNCT07871383 - 3. fázisTaking peopleA Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Where
- Amiens Cedex 1, Lille Cedex, Paris
- Életkor
- 2 év to 17 év
- People
- 90 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05509777 · EU 2024-511472-32-00 - 3. fázisTaking peopleComparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial
- Where
- Amiens Cedex 1, Aurillac Cedex, Bayonne, Besancon Cedex, Caen, Clermont-Ferrand, Clichy, Colmar Cedex, Creteil Cedex, Lille, Montpellier Cedex 5, Nantes, Neuilly-Sur-Seine, Nice, Paris Cedex 10, Pessac, Pierre-Bénite, Reims Cedex, Rennes, Roubaix, Rouen Cedex, St Etienne Cedex 2, Toulon, Toulouse Cedex 9, Tourcoing Cedex, Tours, Valence, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 166
- Run by
- Centre Hospitalier Universitaire Amiens Picardie
See details and how to join2024-514633-38-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Where
- Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Rennes, Saint-Priest-en-Jarez, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év to 75 év
- People
- 590 worldwide
- Run by
- AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00